Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael White

Showing results (441-450 of 496) with videos related to

Pageof 50
Sort By:
The Journal of Cell Biology|January 29, 2024
Identification of small molecule inhibitors of G3BP-driven stress granule formationBrian D Freibaum, James Messing, Haruko Nakamura, et al.
Malaria Journal|September 10, 2024
CUREMA project: a further step towards malaria elimination among hard-to-reach and mobile populationsAlice Sanna, Yann Lambert, Irene Jimeno Maroto, et al.
Memorias Do Instituto Oswaldo Cruz|June 29, 2022
Prevalence and force of Plasmodium vivax blood-stage infection and associated clinical malaria burden in the Brazilian AmazonWuelton Monteiro, Stephan Karl, Andrea Kuehn, et al.
Journal of Pathology Informatics|November 28, 2024
A multicenter study to evaluate the analytical precision by pathologists using the Aperio GT 450 DXThomas W Bauer, Matthew G Hanna, Kelly D Smith, et al.
Trials|August 7, 2025
Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritisEma-Louise Long, James Stanway, Michael White, et al.
The Lancet. Infectious Diseases|March 20, 2025
14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy studyVirak Eng, Dysoley Lek, Sitha Sin, et al.
Viruses|May 25, 2024
Influenza Virus Genomic Surveillance, Arizona, USA, 2023-2024Rabia Maqsood, Matthew F Smith, LaRinda A Holland, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
High versus low dose of 14 days treatment of primaquine in <i>Plasmodium vivax</i> infected patients in Cambodia: a randomised open-label efficacy studyVirak Eng, Dysoley Lek, Sitha Sin, et al.
The Journal of Clinical Investigation|February 23, 2016
A role for genetic susceptibility in sporadic focal segmental glomerulosclerosisHaiyang Yu, Mykyta Artomov, Sebastian Brähler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Fine-scale Spatiotemporal Mapping of Asymptomatic and Clinical Plasmodium falciparum Infections: Epidemiological Evidence for Targeted Malaria Elimination InterventionsMakhtar Niang, Mirco Sandfort, Adja Fatou Mbodj, et al.
Pageof 50

Showing results (441-450 of 496) with videos related to

Sort By:
Pageof 50
The Journal of Cell Biology|January 29, 2024
Identification of small molecule inhibitors of G3BP-driven stress granule formationBrian D Freibaum, James Messing, Haruko Nakamura, et al.
Malaria Journal|September 10, 2024
CUREMA project: a further step towards malaria elimination among hard-to-reach and mobile populationsAlice Sanna, Yann Lambert, Irene Jimeno Maroto, et al.
Memorias Do Instituto Oswaldo Cruz|June 29, 2022
Prevalence and force of Plasmodium vivax blood-stage infection and associated clinical malaria burden in the Brazilian AmazonWuelton Monteiro, Stephan Karl, Andrea Kuehn, et al.
Journal of Pathology Informatics|November 28, 2024
A multicenter study to evaluate the analytical precision by pathologists using the Aperio GT 450 DXThomas W Bauer, Matthew G Hanna, Kelly D Smith, et al.
Trials|August 7, 2025
Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritisEma-Louise Long, James Stanway, Michael White, et al.
The Lancet. Infectious Diseases|March 20, 2025
14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy studyVirak Eng, Dysoley Lek, Sitha Sin, et al.
Viruses|May 25, 2024
Influenza Virus Genomic Surveillance, Arizona, USA, 2023-2024Rabia Maqsood, Matthew F Smith, LaRinda A Holland, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
High versus low dose of 14 days treatment of primaquine in <i>Plasmodium vivax</i> infected patients in Cambodia: a randomised open-label efficacy studyVirak Eng, Dysoley Lek, Sitha Sin, et al.
The Journal of Clinical Investigation|February 23, 2016
A role for genetic susceptibility in sporadic focal segmental glomerulosclerosisHaiyang Yu, Mykyta Artomov, Sebastian Brähler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Fine-scale Spatiotemporal Mapping of Asymptomatic and Clinical Plasmodium falciparum Infections: Epidemiological Evidence for Targeted Malaria Elimination InterventionsMakhtar Niang, Mirco Sandfort, Adja Fatou Mbodj, et al.
Pageof 50